Form SCHEDULE 13G Aspire Biopharma Holding Filed by: Rubenbauer Alois Ryan III

SCHEDULE 13G

CUSIP No.

1

Names of Reporting Persons

Rubenbauer Alois Ryan III

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 65,000.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 65,000.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

65,000.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.0 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: The percentage of the class beneficially owned by the Reporting Person is based on 1,295,234 shares of Common Stock outstanding, as reported by the Issuer in its Quarterly Report on Form 10-Q for the quarter ended March 31, 2026, filed with the Securities and Exchange Commission on May 15, 2026.

SCHEDULE 13G

Item 1.

(a)

Name of issuer:

Aspire Biopharma Holdings, Inc.

(b)

Address of issuer's principal executive offices:

23150 FASHION DRIVE, SUITE 232, ESTERO, FLORIDA, 33928.

Item 2.

(a)

Name of person filing:

Alois Ryan Rubenbauer III (the "Reporting Person").

(b)

Address or principal business office or, if none, residence:

28100 US Highway N., Suite 303, Clearwater, FL 33761.

(c)

Citizenship:

The Reporting Person is a citizen of the United States of America.

(d)

Title of class of securities:

Common Stock

(e)

CUSIP No.:

Item 3.

If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b)

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

(e)

An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f)

An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g)

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h)

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:

(k)

Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).

Item 4.

Ownership

(a)

Amount beneficially owned:

The information required by Items 4(a)-(c) is set forth in Rows 5-11 of the cover page for the Reporting Person hereto and is incorporated by reference for the Reporting Person.

(b)

Percent of class:

The information required by Items 4(a)-(c) is set forth in Rows 5-11 of the cover page for the Reporting Person hereto and is incorporated by reference for the Reporting Person. %

(c)

Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:

The information required by Items 4(a)-(c) is set forth in Rows 5-11 of the cover page for the Reporting Person hereto and is incorporated by reference for the Reporting Person.

(ii) Shared power to vote or to direct the vote:

The information required by Items 4(a)-(c) is set forth in Rows 5-11 of the cover page for the Reporting Person hereto and is incorporated by reference for the Reporting Person.

(iii) Sole power to dispose or to direct the disposition of:

The information required by Items 4(a)-(c) is set forth in Rows 5-11 of the cover page for the Reporting Person hereto and is incorporated by reference for the Reporting Person.

(iv) Shared power to dispose or to direct the disposition of:

The information required by Items 4(a)-(c) is set forth in Rows 5-11 of the cover page for the Reporting Person hereto and is incorporated by reference for the Reporting Person.

Item 5.

Ownership of 5 Percent or Less of a Class.

Item 6.

Ownership of more than 5 Percent on Behalf of Another Person.

Not Applicable

Item 7.

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.

Not Applicable

Item 8.

Identification and Classification of Members of the Group.

Not Applicable

Item 9.

Notice of Dissolution of Group.

Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Rubenbauer Alois Ryan III

Signature:	/s/ Alois Ryan Rubenbauer III
Name/Title:	Reporting Person
Date:	07/02/2026

Form SCHEDULE 13G Aspire Biopharma Holding Filed by: Rubenbauer Alois Ryan III

You May Also Be Interested In

Create E-mail Alert Related Categories

Related Entities

Sign up for StreetInsider Free!

Free News Feed